Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial

IMPORTANCE: Fenfluramine treatment may reduce monthly convulsive seizure frequency in patients with Dravet syndrome who have poor seizure control with their current stiripentol-containing antiepileptic drug regimens. OBJECTIVE: To determine whether fenfluramine reduced monthly convulsive seizure fre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Neurol
Autors principals: Nabbout, Rima, Mistry, Arun, Zuberi, Sameer, Villeneuve, Nathalie, Gil-Nagel, Antonio, Sanchez-Carpintero, Rocio, Stephani, Ulrich, Laux, Linda, Wirrell, Elaine, Knupp, Kelly, Chiron, Catherine, Farfel, Gail, Galer, Bradley S., Morrison, Glenn, Lock, Michael, Agarwal, Anupam, Auvin, Stéphane
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902175/
https://ncbi.nlm.nih.gov/pubmed/31790543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2019.4113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars